Compare GME & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GME | VCEL |
|---|---|---|
| Founded | 1996 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronics Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 1.7B |
| IPO Year | 2005 | 1996 |
| Metric | GME | VCEL |
|---|---|---|
| Price | $22.89 | $33.02 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $13.50 | ★ $58.50 |
| AVG Volume (30 Days) | ★ 4.3M | 527.5K |
| Earning Date | 03-24-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1550.00 | 60.00 |
| EPS | ★ 0.55 | 0.32 |
| Revenue | ★ $3,823,000,000.00 | $276,259,000.00 |
| Revenue This Year | $9.86 | $19.10 |
| Revenue Next Year | $2.83 | $17.95 |
| P/E Ratio | ★ $40.92 | $98.34 |
| Revenue Growth | N/A | ★ 16.45 |
| 52 Week Low | $19.94 | $29.24 |
| 52 Week High | $35.81 | $48.75 |
| Indicator | GME | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 44.56 |
| Support Level | $22.79 | $31.24 |
| Resistance Level | $23.19 | $38.48 |
| Average True Range (ATR) | 0.66 | 1.36 |
| MACD | -0.18 | 0.01 |
| Stochastic Oscillator | 20.23 | 52.77 |
GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. The company sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States. The company categorizes its products in three categories: Hardware and accessories, Software, and Collectibles. The company generates the majority of its revenue from the sale of Hardware and accessories products.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.